- Home
- DNMX vs PROF Comparison
DNMX vs PROF Comparison
Compare DNMX & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNMX | PROF |
|---|---|---|
| Founded | 2025 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.4M | 270.7M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | DNMX | PROF |
|---|---|---|
| Price | $9.93 | $5.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 52.6K | ★ 207.9K |
| Earning Date | 01-01-0001 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.89 |
| EPS | N/A | ★ 1.41 |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | N/A | $61.40 |
| Revenue Next Year | N/A | $101.18 |
| P/E Ratio | ★ N/A | $3.79 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $9.87 | $3.90 |
| 52 Week High | $9.99 | $8.95 |
Technical Indicators
Market Signals| Indicator | DNMX | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 50.42 | 33.38 |
| Support Level | $9.87 | $5.52 |
| Resistance Level | $9.99 | $5.86 |
| Average True Range (ATR) | 0.02 | 0.50 |
| MACD | -0.00 | -0.19 |
| Stochastic Oscillator | 42.86 | 20.13 |
Price Performance
Historical ComparisonAbout DNMX Dynamix Corporation III Class A Ordinary Shares
Dynamix Corp III is a a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.